A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
Clinical trial NCT01663272 · COMPLETED
Trial details
- NCT number
- NCT01663272
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2015-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.